Novo-Nordisk A/S/ DK0062498333 /
2024-08-30 9:55:34 PM | Chg. +3.5574 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
138.7425USD | +2.63% | 28,776 Turnover: 106,430.2304 |
-Bid Size: - | -Ask Size: - | 477.27 bill.USD | - | - |
Newsfile Corp
08-28
The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire
08-14
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire
08-06
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire
08-01
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Dire...
GlobeNewswire
07-11
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
GlobeNewswire
07-11
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire
07-11
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire
07-08
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into...